Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer [Phase 2]
Phase 2 study of oral ENMD-2076 in ovarian, fallopian tube, and peritoneal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma [Phase 2]
A Phase II study evaluated dasatinib (Sprycel) in patients with persistent or recurrent epithelial ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating a combination of docetaxel, trabectedin, and G-CSF or pegfilgrastim in patients with recurrent or persistent ovaria…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update evaluating topotecan for recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer, with resu…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer [Phase 3]
This entry reports the completion of a Phase 3 trial evaluating carboplatin and paclitaxel with or without gemcitabine in patients with ovar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma [Phase 2]
Phase 2 trial evaluating oxaliplatin, gemcitabine, and bevacizumab in women with recurrent Mullerian carcinomas; the study (NCT00418093) was…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Study of Ramucirumab in Ovarian Cancer [Phase 2]
Phase 2 trial update of ramucirumab in ovarian cancer and related gynecologic cancers has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating mifepristone for recurrent or persistent ovarian epithelial, primary peritoneal, or fallopian tube cancer has com…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer [Phase 3]
This Phase 3 trial evaluated early post-operative enteral feeding in patients with advanced epithelial ovarian cancer, including peritoneal …
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
A completed clinical trial comparing epidural analgesia versus patient-controlled analgesia for gynecologic cancer surgery, with conditions …
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 trial evaluating the combination of Bevacizumab and Erlotinib in patients with recurrent or metastatic ovarian epithelial cancer, …
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor [Phase 2]
Phase 2 randomized multicenter trial evaluating SU11248 (sunitinib) in platinum-refractory epithelial ovarian cancer and peritoneal cancers,…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Study of Paclitaxel in Patients With Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating paclitaxel in patients with epithelial ovarian cancer, primary peritoneal cancer, and fallopian tube cancer has c…
-
CLINICAL_TRIALS trial_result · 2014-01-21Clinical Trial Update: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin [Phase 2]
Phase 2 trial evaluating belinostat plus carboplatin in recurrent or persistent carboplatin/ cisplatin–refractory ovarian epithelial, fallop…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse [Phase 3]
Phase 3 trial comparing Caelyx (liposomal doxorubicin) plus carboplatin with paclitaxel plus carboplatin in late-relapsed epithelial ovarian…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 clinical trial update describes a study of docetaxel plus carboplatin for patients with Stage III or IV ovarian, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
A Phase 2 study evaluating CP-547,632 in recurrent or persistent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating eribulin mesylate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing early chemotherapy based on CA 125 levels versus delayed chemotherapy in recurrent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies [Phase 2]
This report covers results from a Phase 2 trial using the CyberKnife stereotactic radiosurgery system to treat advanced or recurrent gynecol…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating Hu3S193 in women with ovarian epithelial, primary peritoneal, or fallopian tube cancer has completed, and results h…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update of temsirolimus in refractory or recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer; results po…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating irinotecan in patients with refractory ovarian epithelial, primary peritoneal, or fallopian tube cancer …
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update of a monoclonal antibody therapy for ovarian, fallopian tube, and primary peritoneal cancer sponsored by AltaR…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study [NA]
A feasibility trial evaluating yoga to improve quality of life in patients with ovarian, fallopian tube, or primary peritoneal cancer receiv…